Received Mar 23, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| HEP | HEP B (HEPLISAV-B) | DYNAVAX TECHNOLOGIES CORPORATION | 1 | 947358 | IM / LA |
Systemic: Allergic: Itch (specify: facial area, extremeties)-Medium, Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Additional Details: pt received heplisav b first dose on march 17 2026 and started having red rash itchiness in scalp and forehead 20 minutes after receiving the vaccine pt was given 15 ml of benadryl 12.5 mg per 5 ml liquid medication pt will be followed up
vancomycin,phenergan